In February 2008 Kevin Sidow began his role as President and Chief Executive Officer for Moximed® Inc. Prior to his current role, he was President and CEO for St. Francis Medical Technologies, Inc. Founded in 1997, St. Francis Medical Technologies was a privately held, venture funded company focused on developing innovative treatments for patients suffering from degenerative spinal disorders. In January 2007, St. Francis Medical Technologies, Inc. was sold for $725 million to Kyphon Inc. Previously, Kevin was the Worldwide President of DePuy Inc., where he oversaw the global orthopedic, spine, trauma, and sports medicine businesses with annual revenue responsibility of over $3 billion. Kevin holds a BS in Accounting from West Virginia University.
Anton is a founding member of the Moximed Inc. team. Since its inception in 2006, he has lead the concept creation and product development activities in the role of VP of Research and Development. Prior to joining Moximed Inc., Anton held a variety of R&D management positions at Abbott Vascular, a division of Abbott Laboratories, including Director of Research and Development for Coronary Technologies. In 2005, Dr. Clifford was inducted into Abbott Laboratories Volweiler Society, a society established to recognize the company’s most distinguished scientists and engineers, and was awarded researcher of the year for outstanding contributions made to Abbott Laboratories vascular stent research. Dr. Clifford started his career in medical devices at MedNova Ltd. in 1998, where he led the Carotid Stent Development Program. Anton has produced novel medical technology inventions in the fields of vascular, otology, rhinology and orthopedic devices that have resulted in more than 90 filed US & International patents and multiple scientific publications. Dr. Clifford has holds a BSc and PhD in Materials Science from the University of Limerick, Ireland.
Ms. Yamut has more than 20 years of experience in the medical device industry. She specializes in getting start-up companies their regulatory/clinical approvals to either begin a clinical trial or commence a product commercial launch, domestically and internationally. Her experience includes authoring various FDA submissions, running clinical operations, and developing quality systems. Ms. Yamut also has extensive experience in gaining OUS approvals for clinical investigations and/or product launch in Europe, North America, South America, Australia, Asia, and Africa. Prior to joining Moximed, she has held several management positions at various start-up companies which include Vice President of Regulatory and Clinical Affairs at CHF Technologies and Cabochon Aesthetics (acquired by Ulthera), Sr. Director of Clinical and Regulatory Affairs at Spinal Kinetics and Relievant MedSystems, Director of Regulatory and Quality Affairs at Cardiovention, Inc., and Sr. Manager of Regulatory and Quality Affairs at Kyphon, Inc. (acquired by Medtronic) and General Surgical Innovations (acquired by Tyco Healthcare). Ms. Yamut studied Business Management and Administration at University of California and at Stanford Graduate School of Business.
Luigi joined Moximed Inc. in January 2011 with over 15 years experience in the orthopedic field. Prior to joining Moximed Inc., Luigi was the VP of Sales and Strategic Business Development for Smith & Nephew AG where he was responsible for Southern Europe, overseeing revenues of $130 million and 220 employees. Prior to that, he held management positions at Plus Orthopedics AG and Centerpulse Orthopedics, Italy. Luigi is also the Co-Founder for Sevika Medical AG. He has achieved an excellent reputation and a history of success throughout the industry. Luigi holds a Master of Science in Mechanical Engineering from the Federal Institute of Technology-ETH Zurich, he is fluent in five languages and currently resides in Zurich.
Christine joined Moximed Inc. in February 2008. Christine has over 20 years experience in Business and Human Capital Management. Prior to joining Moximed Inc., Christine held the position of Director of HR and Administration for St. Francis Medical Technologies. Christine played a pivotal role in the acquisition of St. Francis by Kyphon, Inc and was a key member of the transition team following the sale. Prior to that, Christine held Business Management roles of increasing responsibility in the ophthalmology field. Christine holds a BS in Behavioral Science from California State Polytechnic University, Pomona and a BA in Business Administration from the University of California, Los Angeles.
Keith joined Moximed Inc. in March 2010. Keith has over a decade of experience in the medical device field, with a cross-functional background in multiple industry segments. Recently, Keith was a Manager of Business Development for Maquet Cardiovascular (formerly the Cardiac and Vascular Surgery Divisions of Boston Scientific). He has previous product marketing and clinical sales experience with Guidant’s Vascular Intervention, Cardiac Rhythm Management, and Cardiac Surgery business units. Prior to that, he held roles in R&D and Project Management for Guidant. Keith holds an MBA from The Tuck School of Business at Dartmouth and a BS in Mechanical Engineering from the University of California, Berkeley.